Prevalence of Restless Legs Syndrome and Its Effects on Sleep and Health-Related Quality of Life in Patients With Heart Failure.


Journal

Journal of cardiac failure
ISSN: 1532-8414
Titre abrégé: J Card Fail
Pays: United States
ID NLM: 9442138

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 26 03 2019
revised: 03 07 2019
accepted: 20 08 2019
pubmed: 29 9 2019
medline: 14 8 2020
entrez: 28 9 2019
Statut: ppublish

Résumé

Restless legs syndrome (RLS) is a neurological disorder characterized by leg restlessness and dysesthesia. Although the relationship between RLS and heart failure (HF) has been reported, the prevalence and clinical significance of RLS in patients with HF remain to be elucidated. We enrolled consecutive patients with HF who were admitted to our institutions. RLS was diagnosed using the International Restless Legs Syndrome Study Group criteria. Subjective sleepiness, sleep quality, and quality of life (QoL) were assessed using the Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), and 8-item Short Form (SF-8), respectively. Among the 133 patients, 18 (13.6%) had RLS and were younger than those without RLS (62.4±13.4 vs 70.0±12.2, P = .017). The RLS group had significantly disrupted sleep quality and QoL, with greater PSQI score (8.0±3.2 vs 5.9±3.3, P = .015) and lower SF-8 physical component summary (PCS) score (35.6±6.5 vs 40.7±9.5, P = .031), despite similar ESS and SF-8 mental component summary scores. In the multivariable regression analysis, RLS was associated with greater PSQI (β=0.211; P = .014) and lower PCS score (β=-0.177; P = .045). In the patients with HF, RLS was prevalent, and sleep quality and QoL may be disrupted by RLS.

Sections du résumé

BACKGROUND BACKGROUND
Restless legs syndrome (RLS) is a neurological disorder characterized by leg restlessness and dysesthesia. Although the relationship between RLS and heart failure (HF) has been reported, the prevalence and clinical significance of RLS in patients with HF remain to be elucidated.
METHODS AND RESULTS RESULTS
We enrolled consecutive patients with HF who were admitted to our institutions. RLS was diagnosed using the International Restless Legs Syndrome Study Group criteria. Subjective sleepiness, sleep quality, and quality of life (QoL) were assessed using the Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), and 8-item Short Form (SF-8), respectively. Among the 133 patients, 18 (13.6%) had RLS and were younger than those without RLS (62.4±13.4 vs 70.0±12.2, P = .017). The RLS group had significantly disrupted sleep quality and QoL, with greater PSQI score (8.0±3.2 vs 5.9±3.3, P = .015) and lower SF-8 physical component summary (PCS) score (35.6±6.5 vs 40.7±9.5, P = .031), despite similar ESS and SF-8 mental component summary scores. In the multivariable regression analysis, RLS was associated with greater PSQI (β=0.211; P = .014) and lower PCS score (β=-0.177; P = .045).
CONCLUSION CONCLUSIONS
In the patients with HF, RLS was prevalent, and sleep quality and QoL may be disrupted by RLS.

Identifiants

pubmed: 31560959
pii: S1071-9164(19)30328-8
doi: 10.1016/j.cardfail.2019.08.022
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

837-842

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Shoichiro Yatsu (S)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan; Department of Cardiovascular Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan.

Takatoshi Kasai (T)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan; Sleep and Sleep Disordered Breathing Center, Juntendo University Hospital, Tokyo, Japan. Electronic address: kasai-t@mx6.nisiq.net.

Shoko Suda (S)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Masaru Hiki (M)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Hiroki Matsumoto (H)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Sayaki Ishiwata (S)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Akihiro Sato (A)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Nanako Shiroshita (N)

Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Mitsue Kato (M)

Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Fusae Kawana (F)

Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Azusa Murata (A)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Megumi Shimizu (M)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Jun Shitara (J)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Takao Kato (T)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Eiryu Sai (E)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan; Department of Cardiovascular Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan.

Naotake Yanagisawa (N)

Clinical Research and Trial Center, Juntendo University, Tokyo, Japan.

Katsumi Miyauchi (K)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan; Department of Cardiovascular Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan.

Hiroyuki Daida (H)

Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH